MarketInOut Stock Screener Log In | Sign Up
 

SELLAS Life Sciences Group Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
SELLAS Life Sciences Group Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,269.87 mln
Float200 mln
Earnings Date11/18/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

55 / 100
Slightly ahead

Debt / Equity

0.01
Debt-free

ROE

-41.86
Deeply negative

ROA

-38.48
Deeply negative

Business Description

SELLAS Life Sciences Group is a New York-based biopharmaceutical company working to bring new cancer treatments to patients. Its two main drug candidates target cancer through different mechanisms ? one by training the immune system to fight tumors, and the other by blocking a protein that helps cancer cells grow. The company works alongside well-known partners, including Merck and Memorial Sloan Kettering Cancer Center, to advance these treatments through clinical trials covering a range of cancer types.

Key Fundamentals

EPS-0.21
ROE-41.86
ROIC-752
ROA-38.48
EBITDA, mln-32.46
EV / EBITDA-67.30
EV / EBIT-67.30

Quote Details

Last 11.54
Change 0.19 (1.67%)
Open 11.29
Volume 3,246,056
Turnover 37,459,488
Average Volume 5,535,328

Financial Ratios

Leverage Ratio1.06
Current Ratio18.83
Price / Book18.28
Price / Tangible Book18.55
Debt / Equity0.01

Financial Strength

Piotroski F-Score 4 / 9
Short Ratio8.57
Short % of Float27.41

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 15.63% 97 / 100   
1 Month -3.67% 44 / 100   
2 Months -7.53% 36 / 100   
6 Months 159% 99 / 100   
1 Year 492% 100 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog